Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer

7 Jul 2023

Abstract excerpt

Background: Centrosomal Protein 55 (CEP55) was initially described as a main participant in the final stage of cytokinesis. Further research identified CEP55 as a cancer-testis antigen (CTA) that is aberrantly expressed in different malignancies and a cancer vaccination candidate. The current study aimed to disclose the complete expression of CEP55, its effect on various malignancy prognoses, and its role in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37484531
DOI: 10.3389/fmolb.2023.1198557

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancerPMID 37484531Read ↗

CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental VerificationSemantic proximity Read ↗

CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancersSemantic proximity Read ↗

Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver CancerSemantic proximity Read ↗

Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal CancerSemantic proximity Read ↗

Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinomaSemantic proximity Read ↗

The role of CCT5 in human tumors: a pan-cancer analysisSemantic proximity Read ↗

Pan-cancer analysis reveals immunological and prognostic significance of CCT5 in human tumorsSemantic proximity Read ↗

CEP72 Promotes Malignant Progression and Shapes the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Integrated Multi-cohort Bioinformatics and In Vitro ValidationSemantic proximity Read ↗

Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-CancersSemantic proximity Read ↗

A novel molecular subtype identification applied to individualized treatment of mRNA vaccines for hepatocellular carcinomaSemantic proximity Read ↗

Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysisSemantic proximity Read ↗

Pan-cancer analysis revealed prognosis value and immunological relevance of RAMPsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.